Torrent Pharmaceuticals Limited
TORNTPHARM
Rangering i aksjer
#1200
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Aksjekurs
$50.31
Sist synkronisert: 2026-10-19
Markedsverdi
$19.14B
Endring (1 dag)
-0.14%
Endring (1 år)
23.32%
Land
IN
Handel Torrent Pharmaceuticals Limited (TORNTPHARM)
Kategori
Healthcare
Antall utestående aksjer for Torrent Pharmaceuticals Limited (TORNTPHARM)
Antall utestående aksjer per June 2026: 338.45M
Ifølge Torrent Pharmaceuticals Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 338.45M. Ved slutten av March 2024 hadde selskapet 338.45M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Torrent Pharmaceuticals Limited (TORNTPHARM) fra 2005 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 338.45M | 0.01% |
| 2025 | 338.41M | -0.01% |
| 2024 | 338.45M | 0.00% |
| 2023 | 338.45M | 0.00% |
| 2022 | 338.45M | 0.00% |
| 2021 | 338.45M | 0.00% |
| 2020 | 338.45M | 0.00% |
| 2019 | 338.45M | 0.00% |
| 2018 | 338.45M | 0.00% |
| 2017 | 338.45M | 0.00% |
| 2016 | 338.45M | 0.00% |
| 2015 | 338.45M | 0.00% |
| 2014 | 338.45M | 0.00% |
| 2013 | 338.45M | 0.00% |
| 2012 | 338.45M | 0.00% |
| 2011 | 338.44M | 0.00% |
| 2010 | 338.44M | 0.00% |
| 2009 | 338.44M | 0.00% |
| 2008 | 338.44M | 0.00% |
| 2007 | 338.44M | 0.00% |
| 2006 | 338.44M | 0.00% |
| 2005 | 338.44M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 608.93% |
IN
|
